Relx Plc (NYSE:RELX) Shares Sold by Gradient Investments LLC

Gradient Investments LLC decreased its holdings in Relx Plc (NYSE:RELX – Get Rating) by 4.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 13,871 shares of the technology company’s stock after selling 603 shares during the quarter. Gradient Investments LLC’s holdings in Relx were worth $384,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Relx by 4.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 8,746 shares of the technology company’s stock worth $272,000 after acquiring an additional 386 shares in the last quarter. Atria Investments LLC lifted its stake in shares of Relx by 1.1% in the second quarter. Atria Investments LLC now owns 50,713 shares of the technology company’s stock worth $1,366,000 after acquiring an additional 538 shares in the last quarter. Private Advisor Group LLC lifted its stake in shares of Relx by 7.3% in the first quarter. Private Advisor Group LLC now owns 8,133 shares of the technology company’s stock worth $253,000 after acquiring an additional 554 shares in the last quarter. Pinnacle Wealth Planning Services Inc. lifted its stake in shares of Relx by 4.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 13,077 shares of the technology company’s stock worth $318,000 after acquiring an additional 587 shares in the last quarter. Finally, Edge Capital Group LLC lifted its stake in shares of Relx by 0.3% in the third quarter. Edge Capital Group LLC now owns 210,754 shares of the technology company’s stock worth $5,123,000 after acquiring an additional 591 shares in the last quarter. Institutional investors and hedge funds own 3.41% of the company’s stock.

Relx Stock Down 0.9 %

Shares of Relx stock opened at $30.68 on Friday. The company has a current ratio of 0.59, a quick ratio of 0.53 and a debt-to-equity ratio of 1.56. The business’s 50 day simple moving average is $29.77 and its 200-day simple moving average is $27.71. Relx Plc has a twelve month low of $23.39 and a twelve month high of $32.24.

Relx Increases Dividend

The business also recently declared a Semi-Annual dividend, which will be paid on Monday, June 12th. Stockholders of record on Friday, April 28th will be given a dividend of $0.466 per share. This is a boost from Relx’s previous Semi-Annual dividend of $0.44. The ex-dividend date of this dividend is Thursday, April 27th.

Analysts Set New Price Targets

Several analysts have issued reports on RELX shares. Credit Suisse Group upped their price objective on Relx from GBX 2,800 ($34.13) to GBX 2,860 ($34.86) in a research note on Friday, February 17th. Barclays cut Relx from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, January 31st. Morgan Stanley cut their price objective on Relx from GBX 3,020 ($36.81) to GBX 2,950 ($35.95) in a research note on Friday, December 16th. JPMorgan Chase & Co. upped their price objective on Relx from GBX 2,810 ($34.25) to GBX 2,840 ($34.61) in a research note on Wednesday. Finally, StockNews.com started coverage on Relx in a research note on Thursday. They set a “hold” rating on the stock.

Relx Company Profile

(Get Rating)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.